Sonoma Pharmaceuticals, Inc. (SNOA) financial statements (2021 and earlier)

Company profile

Business Address 645 MOLLY LANE, SUITE 150
WOODSTOCK, GA 30189
State of Incorp. DE
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments644101776
Cash and cash equivalents644101776
Receivables4432222
Inventory, net of allowances, customer advances and progress billings3233221
Inventory3233221
Prepaid expense 221111
Other undisclosed current assets300100 
Total current assets:16121216231310
Noncurrent Assets
Operating lease, right-of-use asset11
Property, plant and equipment0011111
Long-term investments and receivables      5
Long-term investments      5
Other noncurrent assets0000000
Other undisclosed noncurrent assets11111  
Total noncurrent assets:2223315
TOTAL ASSETS:18151419251415
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2433332
Accounts payable2211111
Accrued liabilities 111110
Employee-related liabilities 111111
Taxes payable    0  
Deferred revenue00
Debt 000000
Derivative instruments and hedges, liabilities      0
Deferred revenue and credits 011
Other liabilities  0    
Other undisclosed current liabilities10000  
Total current liabilities:4543343
Noncurrent Liabilities
Long-term debt and lease obligation21000  
Long-term debt, excluding current maturities1 000  
Capital lease obligations 00  
Operating lease, liability01
Liabilities, other than long-term debt00  100
Deferred revenue and credits 100
Deferred revenue00
Other undisclosed noncurrent liabilities  00   
Total noncurrent liabilities:2101100
Total liabilities:6644443
Stockholders' equity
Stockholders' equity attributable to parent1291015211012
Common stock0000000
Additional paid in capital189187184177169166158
Accumulated other comprehensive loss(4)(6)(4)(4)(4)(4)(4)
Accumulated deficit(173)(172)(169)(157)(143)(152)(142)
Total stockholders' equity:1291015211012
TOTAL LIABILITIES AND EQUITY:18151419251415

Income statement (P&L) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Revenues24191917131514
Revenue, net 131514
Cost of revenue(14)(11)(10)(9)(7)(8)(7)
Cost of goods and services sold(14)(11)(0)(0)(7)(8)(7)
Gross profit:10897677
Operating expenses(10)(15)(20)(21)(19)(17)(14)
Operating loss:(1)(7)(11)(14)(13)(10)(7)
Nonoperating income (expense)00000(0)(5)
Investment income, nonoperating000000(5)
Other nonoperating expense     (0)(0)
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(1)(7)(11)(14)(13)(10)(11)
Other undisclosed income (loss) from continuing operations before income taxes 4(0)(0)0  
Loss from continuing operations before income taxes:(1)(3)(11)(14)(13)(10)(11)
Income tax expense (benefit) (0)(0) 4 3
Other undisclosed loss from continuing operations(1)      
Loss from continuing operations:(1)(3)(12)(14)(9)(10)(9)
Income from discontinued operations2   18  
Net income (loss):1(3)(12)(14)9(10)(9)
Other undisclosed net income attributable to parent     01
Net income (loss) available to common stockholders, diluted:1(3)(12)(14)9(10)(8)

Comprehensive Income ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Net income (loss):1(3)(12)(14)9(10)(9)
Other comprehensive income (loss) (4)(12)(14)9(11) 
Comprehensive income (loss):1(7)(24)(28)18(21)(9)
Other undisclosed comprehensive income, net of tax, attributable to parent2     0
Comprehensive income (loss), net of tax, attributable to parent:2(7)(24)(28)18(21)(9)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: